About Quanterix
Quanterix is a leading company that specializes in developing and commercializing ultra-sensitive biomarker detection systems. The company's innovative technology, Simoa®, has revolutionized the field of precision health by enabling researchers to detect and measure biomarkers with unprecedented accuracy.
At Quanterix, we are committed to advancing the science of precision health through our cutting-edge technology. Our Simoa® platform is based on digital ELISA (enzyme-linked immunosorbent assay) technology, which allows for the detection of proteins at concentrations as low as femtograms per milliliter. This level of sensitivity is critical for detecting and measuring biomarkers that are present in very low concentrations in biological samples.
Our Simoa® platform has been used by researchers across a wide range of fields, including oncology, neurology, cardiology, infectious diseases, and more. By providing researchers with highly sensitive tools for detecting and measuring biomarkers, we are helping to accelerate the development of new diagnostics and therapies for a variety of diseases.
One key advantage of our Simoa® technology is its ability to detect multiple analytes simultaneously from a single sample. This means that researchers can obtain more comprehensive information about disease states or treatment responses from a single sample than would be possible using traditional methods.
In addition to our core business of developing ultra-sensitive biomarker detection systems, Quanterix also offers contract research services through its Accelerator Lab Services division. This division provides custom assay development services as well as sample testing services using Quanterix's proprietary platforms.
At Quanterix, we pride ourselves on being at the forefront of innovation in precision health. Our team includes experts in biology, chemistry, engineering, software development and other fields who work together to develop new technologies that push the boundaries of what is possible in biomarker detection.
If you're interested in learning more about how Quanterix's revolutionary biomarker testing technology can help advance your research goals or improve patient outcomes please visit our website or contact us directly!